Modelling methods for pharmacoeconomics and health technology assessment: an overview and guide

PharmacoEconomics
James E Stahl

Abstract

This paper provides an overview of, and guidance as to when, why and how to choose and use, different simulation modelling methods as applied to healthcare. What simulation is and why it is necessary in addressing healthcare problems are discussed. In addition, key criteria for choosing an appropriate method (project type, population resolution, interactivity, treatment of time and space, resource constraints, autonomy and how knowledge is embedded) are covered. Key concepts for each method, moving from the simplest to most complex methods, are reviewed in some detail.

References

Jun 1, 1986·The American Journal of Medicine·D A PlanteS G Pauker
Jan 1, 1985·Medical Decision Making : an International Journal of the Society for Medical Decision Making·P DoubiletB J McNeil
Jan 1, 1983·Medical Decision Making : an International Journal of the Society for Medical Decision Making·J R Beck, S G Pauker
Oct 1, 1993·Medical Decision Making : an International Journal of the Society for Medical Decision Making·F A Sonnenberg, J R Beck
Jul 1, 1997·Medical Decision Making : an International Journal of the Society for Medical Decision Making·D K OwensR F Nease
Jul 1, 1997·Medical Decision Making : an International Journal of the Society for Medical Decision Making·R F Nease, D K Owens
Oct 2, 1997·The New England Journal of Medicine·H Varmus, D Satcher
Nov 14, 1997·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·B S DeanA Van Ackere
Dec 10, 1991·PharmacoEconomics·D A Freund, R S Dittus
Feb 6, 1998·PharmacoEconomics·M J Nuijten
Sep 4, 1998·Journal of Health Services Research & Policy·K Taylor, D Lane
Dec 12, 1983·Socio-economic Planning Sciences·R G Coyle
Dec 22, 1999·Statistics in Medicine·W J EdmundsD J Nokes
Aug 10, 2000·Medical Decision Making : an International Journal of the Society for Medical Decision Making·E F HalpernG S Gazelle
Sep 8, 2000·PharmacoEconomics·A H Briggs
Jun 14, 2003·Stroke; a Journal of Cerebral Circulation·Mark H EckmanSteven M Greenberg
Apr 22, 2004·Journal of Health Services Research & Policy·Pelham BartonSuzanne Robinson
May 22, 2004·Physics in Medicine and Biology·Jürgen MeyerJason N Doctor
Jul 24, 2004·BMJ : British Medical Journal·Nicholas A Christakis
Sep 11, 2004·Medical Decision Making : an International Journal of the Society for Medical Decision Making·James E StahlG Scott Gazelle
May 11, 2005·International Journal of Hygiene and Environmental Health·Mama HoardJames Helmkamp
May 12, 2005·Revue Scientifique Et Technique·S C MacDiarmid, H J Pharo
May 24, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Vito QuarantaAlexander R A Anderson
Sep 24, 2005·American Journal of Epidemiology·R M ChristleyJ Turner
Aug 31, 2006·Health Economics·Alan BrennanRuth Davies
Oct 3, 2006·Inflammatory Bowel Diseases·Amnon Sonnenberg, Judith F Collins
Feb 14, 2007·The New England Journal of Medicine·Christian SpauldingPatrick W Serruys
Mar 28, 2007·The New England Journal of Medicine·William E BodenUNKNOWN COURAGE Trial Research Group
Apr 6, 2007·The New England Journal of Medicine·Joshua J FentonJoann G Elmore
Jul 27, 2007·The New England Journal of Medicine·Nicholas A Christakis, James H Fowler
Sep 1, 1949·Journal of the American Statistical Association·N METROPOLIS, S ULAM

❮ Previous
Next ❯

Citations

Mar 3, 2010·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·A S NeubauerA Kampik
Oct 8, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·G Feljandro P RamosOnno C P van Schayck
May 9, 2012·International Journal of Technology Assessment in Health Care·Morgan E LimJean-Eric Tarride
Jul 17, 2013·Journal of Radiation Research·Daniel AblerKen Peach
Nov 11, 2011·BMC Medical Research Methodology·G Feljandro P RamosJohan L Severens
Mar 3, 2012·Cost Effectiveness and Resource Allocation : C/E·Rilana PrengerErwin R Seydel
Mar 4, 2009·PharmacoEconomics·Maurizio Bonati, Silvio Garattini
Jan 31, 2012·PharmacoEconomics·Olivier Ethgen, Baudouin Standaert
Aug 24, 2013·Journal of Public Health·Adrienne F G Alayli-GoebbelsJohan L Severens
Apr 23, 2014·Journal of Pediatric Psychology·Meghan E McGrady
Nov 22, 2011·Expert Review of Pharmacoeconomics & Outcomes Research·Christian BeckerReiner Leidl
Apr 19, 2013·Revista española de cirugía ortopédica y traumatología·J MarB Soler López
Jan 5, 2013·Artificial Intelligence in Medicine·Casey C Bennett, Kris Hauser
Jan 18, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Deborah A MarshallWilliam Crown
Mar 19, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·J Jaime CaroUNKNOWN ISPOR-AMCP-NPC Modeling CER Task Forces
Jun 17, 2009·Clinical Oral Implants Research·P BouchardA Beresniak
Mar 1, 2012·British Journal of Clinical Pharmacology·Geoffrey T Tucker
Feb 1, 2012·Acta Ophthalmologica·Aukje van GestelJan S Schouten
Jan 19, 2012·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·T LehnertH-H König
Sep 25, 2015·Journal of Alzheimer's Disease : JAD·Myriam Soto-GordoaJavier Mar
Jan 24, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Aukje van GestelJohan Severens
Mar 30, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Don HusereauUNKNOWN ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force
Jul 28, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Aukje van GestelJan S A G Schouten
Mar 30, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Beate JahnKarl-Peter Pfeiffer
Sep 25, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·J Jaime CaroUNKNOWN ISPOR-SMDM Modeling Good Research Practices Task Force
Sep 25, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Mark RobertsUNKNOWN ISPOR-SMDM Modeling Good Research Practices Task Force
Sep 25, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jonathan KarnonUNKNOWN ISPOR-SMDM Modeling Good Research Practices Task Force
Sep 10, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jaime J CaroDenis Getsios
Sep 20, 2012·Medical Decision Making : an International Journal of the Society for Medical Decision Making·J Jaime CaroUNKNOWN ISPOR-SMDM Modeling Good Research Practices Task Force
Sep 20, 2012·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Mark RobertsUNKNOWN ISPOR-SMDM Modeling Good Research Practices Task Force
Sep 20, 2012·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Jonathan KarnonJörgen Möller
Apr 7, 2017·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Vibha C A DesaiPamela C Heaton
Jul 24, 2018·Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva·Javier MarJesús Castilla
Jul 26, 2015·Health Economics Review·Stefan Scholz, Thomas Mittendorf

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Richard PitmanISPOR-SMDM Modeling Good Research Practices Task Force
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Uwe SiebertISPOR-SMDM Modeling Good Research Practices Task Force
© 2021 Meta ULC. All rights reserved